glp-1 obesity drug news A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio The GLP-1 Access Gap: Mapping
Description
E.AhreB
de Oliveira Almeida G, Nienktter TF, Balieiro CCA, Pasqualotto E, Cintra JB, Carvalho HCP et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 84.Wang J., Liao B., Wang C., Zhong O., Lei X., Yang Y
21,22 Although clear protective benefits in diabetic retinopathy development and impact on disease progression remain under investigation, GLP-1RAs have been shown to reduce complications from chronic diabetes, such as retinal vein occlusion and cardiovascular disease
